Orion Group Interim Report 1-6/2003 slides
| Source: Orion Oyj
Recommended Reading
-
ORION CORPORATION PRESS RELEASE 21 JULY 2025 at 10:30 EEST Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted...
Read More -
ORION CORPORATION HALF-YEAR FINANCIAL REPORT 1–6/2025 18 JULY 2025 at 12:00 EEST Orion Group Half-Year Financial Report January–June 2025 April–June 2025 Highlights Net sales totalled EUR 416.5...
Read More